TVB
Tyler Van Buren TD Cowen Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Biohaven
BHVN
$1.68B
| $15.87 | $75 |
373%
upside
| Buy | 9 months ago |
|
2
Moderna
MRNA
$9.78B
| $25.14 | $60 |
139%
upside
| Hold | 11 months ago |
|
3
Regeneron Pharmaceuticals
REGN
$60.8B
| $573.38 | $1,200 |
109%
upside
| Buy | 1 year ago |
|
4
Gilead Sciences
GILD
$143B
| $115.05 | $85 |
26%
downside
| Buy | 1 year ago |
|
5
CRISPR Therapeutics
CRSP
$4.99B
| $54.86 | $30 |
45%
downside
| Underperform | 1 year ago |
|
6
Travere Therapeutics
TVTX
$1.93B
| $21.64 | $30 |
39%
upside
| Outperform | 2 years ago |
|
7
Immunocore
IMCR
$1.87B
| $37.20 | $70 |
88%
upside
| Outperform | 3 years ago |
|
|
8
Gilead Sciences
GILD
$143B
| $115.05 | $84 |
27%
downside
| Overweight | 4 years ago |
|
9
Nurix Therapeutics
NRIX
$758M
| $9.91 | $40 |
304%
upside
| Overweight | 5 years ago |
|
10
Theravance Biopharma
TBPH
$703M
| $13.95 | $30 |
115%
upside
| Overweight | 5 years ago |
|
11
Gossamer Bio
GOSS
$668M
| $2.94 | $30 |
920%
upside
| Overweight | 5 years ago |
|